What 9 Analyst Ratings Have To Say About DICE Therapeutics
Analysts have provided the following ratings for DICE Therapeutics (NASDAQ:DICE) within the last quarter: Bullish Somewhat Bullish Indifferent…
MoonLake’s Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022
MoonLake Immunotherapeutics (NASDAQ: MLTX) has reportedly engaged an investment bank as the Swiss company looks for a potential sale.
The company focuses on developing antibody-derived treatments for inflammatory skin conditions.
Benzinga’s Top Ratings Upgrades, Downgrades For June 26, 2023
Upgrades According to B. Riley Securities, the prior rating for Identiv Inc (NASDAQ:INVE) was changed from Neutral to…
Benzinga’s Top Ratings Upgrades, Downgrades For June 21, 2023
Upgrades Goldman Sachs upgraded the previous rating for Petroleo Brasileiro SA Petrobras (NYSE:PBR) from Neutral to Buy. Petrobras…
Analyst Expectations for DICE Therapeutics’s Future
Over the past 3 months, 7 analysts have published their opinion on DICE Therapeutics (NASDAQ:DICE) stock. These analysts…
Crude Oil Down 2%; Dragonfly Energy Shares Plunge
U.S. stocks traded lower toward the end of trading, with Dow Jones dropping over 150 points on Tuesday.
The Dow traded down 0.50% to 34,129.29while the NASDAQ fell 0.16% to 13,668.76 The S&P 500, also fell, dropping, 0.33% to 4,395.20.
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Evelo Biosciences (NASDAQ:EVLO) shares increased by 49.2% to $0.18 during Tuesday’s regular session. Trading volume for this…
Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Airspan Networks Holdings Inc. (NYSE: MIMO) shares gained 79.5% to $0.2740.
Dow Dips Over 300 Points; DICE Therapeutics Shares Spike Higher
U.S. stocks traded lower midway through trading, with Dow Jones dropping over 300 points on Tuesday.
The Dow traded down 0.96% to 33,969.42 while the NASDAQ fell 0.74% to 13,588.13. The S&P 500, also fell, dropping, 0.80% to 4,374.24.
Health Care Company Eli Lilly Announces Acquisition of DICE Therapeutics
Eli Lilly (NYSE:LLY) has announced an acquisition of DICE Therapeutics (NASDAQ:DICE) that is expected to be completed in…